Gilead Boosts Sales Forecast on Demand for Covid-19 Drug
Gilead Sciences headquarters in Foster City, California.
Photographer: David Paul Morris/BloombergThis article is for subscribers only.
Gilead Sciences Inc. raised its sales forecast for the year, mostly due to anticipated demand for the Covid treatment Veklury.